Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)

NCT: NCT07728071 · NOT_YET_RECRUITING

NCT IDNCT07728071
StatusNOT_YET_RECRUITING
Start Date2026-07-16
Completion2027-12-31
SponsorChinese University of Hong Kong (OTHER)
First posted
Last updated

Brief Summary

Prospective, single-arm, single-site, post-market device study; all procedures use Veloxion™ per IFU.

Frequently Asked Questions

What is Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)?

Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH) is a clinical trial registered under NCT07728071. Current status: NOT_YET_RECRUITING.

What is the status of NCT07728071?

The current status of NCT07728071 (Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)) is: NOT_YET_RECRUITING.

When did Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH) start?

Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH) started on 2026-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑